Invention Grant
- Patent Title: Use of CGRP antagonist compounds for treatment of psoriasis
- Patent Title (中): 使用CGRP拮抗剂化合物治疗牛皮癣
-
Application No.: US13969288Application Date: 2013-08-16
-
Publication No.: US09585940B2Publication Date: 2017-03-07
- Inventor: Birkir Sveinsson
- Applicant: Birkir Sveinsson
- Applicant Address: IS Bessastadahreppur
- Assignee: Birkir Sveinsson
- Current Assignee: Birkir Sveinsson
- Current Assignee Address: IS Bessastadahreppur
- Agency: Thompson Hine LLP
- Priority: IS6496 20020812
- Main IPC: A61K38/22
- IPC: A61K38/22 ; A61K31/00 ; A61K31/166 ; A61K31/517 ; A61K31/727 ; A61K38/48 ; G01N33/50 ; G01N33/74 ; A61K31/506 ; C07K16/26 ; G01N33/566
Abstract:
The invention provides methods and compositions for treating, preventing and/or remedying psoriasis, based on compounds that have a calcitonin-related gene peptide (CGRP) antagonistic effect. Methods are also disclosed for identifying compounds with CGRP antagonist activity which thereby are suitable candidate compounds for treating psoriasis.
Public/Granted literature
- US20140220030A1 USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS Public/Granted day:2014-08-07
Information query
IPC分类:
